PhysChem and ADME-Tox Prediction :: ACD/
ACD Labs Logo

Percepta for the Desktop

  • Clearly the industry standard PhysChem prediction models, and deserve the position. They are the most consistent predictions that are applicable and usable in more complex models of drug-likeness. Computational Chemist
  • ACD/Labs' physicochemical and ADMET prediction software provides…a surprising wealth of information on compound drug-likeness in a simple to use, intuitive format with excellent output graphics. Bill Simmons, Loyola University
  • The ACD/Labs suite is a core component of our drug discovery toolkit and has much value for us. Medical Research Council Technologies, UK
  • The big advantage of your software is the big 'Easy Button' for all predictions, where you just drop in a structure and hit go, then everything you want is right there. Brian Dean, Genentech
  • The best in silico toxicity software I have used. It was very easy to use, and a lot of information could be obtained. Tim Tam, Apotex Pharma
  • It's nice to have PhysChem, ADME, Tox in one sleek interface, that's very user friendly. Regis Leung-Toung, Apotex Pharma

ACD/Labs' algorithms have been the industry-leading models used by computational chemists around the world for more than a decade. The Percepta platform offers a uniform interface for the prediction of ADME, toxicological, and physicochemical property endpoints, and offers a single interface for the analysis and interpretation of predicted data.


Expert prediction modules provide in-depth understanding of structure-property relationships. The majority of the algorithms can be trained to better reflect proprietary chemical space for even better prediction accuracy and higher relevance to individual projects. Conveniently include your own algorithms too.


Quickly screen and profile compounds for a range of PhysChem and ADMET properties. Color-coded thresholds facilitate interpretation to help focus efforts on compounds with desired characteristics.

Other Links

Want to learn more?

Contact Us